Skip to main content
. 2023 Jun 29;12(13):e029300. doi: 10.1161/JAHA.122.029300

Table 3.

Procedure Characteristics

Study Lesion length, mm, mean±SD or median (IQR) LM disease >50% Px LAD disease % Any LAD disease % RCA disease % LCX disease % SVG disease % Radial access % Rotational atherectomy % Laser atherectomy % Scoring/cutting balloon % Contrast volume , mL Procedural duration , min No. of stents , mean±SD or % Average stent length mm Average stent diameter
Abdelwahab et al 18 18 (12–23)/15 (10–20) 1.3/1.3 NA 45.1/50.4 31.2/25.7 22.5/20.7 5.6/4.8 NA NA NA NA NA NA NA 20 (16–28)/18 (13–24) 3 (2.8–3)/3 (2.8–3)
Richardt et al 23 18.0±12.9/16.6±10.1 1.6/1.9 NA 36.7/43.9 34.6/28.7 22.9/24.0 3.6/1.4 NA NA NA NA NA NA NA 22.1±6.4/20.9±6.6 3.2±0.5/3.1±0.5
Gao et al 22 23.79±15.57/25.32±16.28 3.7/3.6 NA 40.5/43.1 34.0/30.8 20.5/22.3 1.3/0.3 70.1/80.6 NA NA 3.8/1.2 NA NA 2.04±1.09/1.90±1.04 (stents per patient) 29.95±17.71/30.73±17.77 3.02±0.43/3.06±0.47
Shimonaga et al 15 14.6±7.0/22.0±11.7 NA NA 44.1/55.2 32.4/24.1 23.5/20.7 NA NA NA NA NA NA NA 0/1.3±0.5 0/27.5±14.6 0/3.09±0.49
Redfors et al 19 27.3±20.7/27.1±20.0 3.3/3.8 NA 41.8/46.5 44.3/36.3 29.8/31.1 9.4/4.5 5.2/4.3 NA NA NA NA NA 1.71±1.03/1.70±1.00 33.1±23.5/32.4±22.2 NA
Buchanan et al 17 NA 1.8/3 NA 21/36 33/32 20/28 23/0 NA 1.0/4.9 1.6/0.3 19.0/5.4 NA NA 1.17±0.87/1.29±0.95 19±6.4/19±6.7 NA
Lee et al 16 16.4±11.1/19.6±14.1 NA NA 43.3/38.3 38.4/40.8 18.3/20.9 NA NA NA NA NA 190.3±89.2/216.2±123.6 Fluoroscopic time 40.1±64.4/25.5±26.1 1.8±0.5/1.84±0.6 30.2±14.9/30.2±17.1 2.94±0.4/3.08±0.9
Takeuchi et al 20 21.8±12.2/21.5±11.9 NA NA 40.4/52.0 36.8/27.8 18.2/16.4 0.4/0.5 NA 3.6/6.4 NA 69.6/40.9 NA NA 49.3/87.9 NA NA
Tamez et al 14 18.46±11.22/18.40±10.57 NA NA NA NA NA NA NA 0.9/1.6 0.5/0.1 17.3/3.8 NA NA DES G1/G2 76 939 (90.7%), 640 432 (77.7%); and BMS G1/G2 7876 (9.3%), 184 142 (22.3%) 19.20±7.5518.53±7.06 2.99±0.50 .96±0.52
Tang et al 12 NA 1.4/5.9 NA 39.1/44.8 50.7/46.8 26.1/26.6 NA 77.5/81.5 NA NA NA 239 (180, 280)/250 (200, 300) NA NA NA NA
Wang et al 13 24.2±17.3/16.9±11.5 83.5/84.9 NA NA NA NA 51.09±30.72/56.90±37.91 75.4/73.9 26.19±5.28/26.10±5.25 3.00±0.41/2.91±0.40
Azzalini et al 21 Lesion length >20 mm: 68.5%/42.5% NA NA 27.0/28.6 55.0/51.8 18.0/19.6 NA 34.2/42.7 NA NA NA 302±134/332±137 115±75/128±69 (min) 2.34±1.31/2.20±1.27 (stents per patient) 77.3±49.7/69.1±40.7 NA

BMS indicates bare‐metal stent; DES, drug‐eluting stent; IQR, interquartile range; LAD, left anterior descending artery; LM, left main coronary artery; NA, not applicable; Px, proximal; RCA, right coronary artery and SVG, saphenous vein graft.

HHS Vulnerability Disclosure